Apr 30, 2019 7:00am EDT NeoGenomics Reports 51% Revenue Growth to Record $96 Million in the First Quarter
Apr 02, 2019 5:20pm EDT NeoGenomics to Present at 18th Annual Needham & Company Health Care Conference
Mar 11, 2019 7:00am EDT NeoGenomics Launches Immuno-Oncology Companion Diagnostic Test for Triple Negative Breast Cancer in Conjunction with FDA Approval for TECENTRIQ(R)
Mar 07, 2019 4:50pm EST NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference
